Target intelligence / Profile preview

Mycobacterium leprae cell membrane (M. leprae cell membrane)

Target
M. leprae cell membrane
Molecular classification
Bacterial cell membrane, Lipid bilayer
01

Overview

The Mycobacterium leprae cell membrane is a vital lipid bilayer that functions as a selective permeability barrier and the primary site for the bacterium's energy transduction processes. It houses essential membrane-bound complexes, including the electron transport chain and the F-ATP synthase enzyme, which are critical for the survival of this obligate intracellular pathogen (Frontiers in Microbiology, 2017; NIH, 2013). The membrane also serves as a scaffold for the synthesis of the complex mycobacterial cell wall and contains unique glycolipids, such as phenolic glycolipid-1 (PGL-1), which facilitate interaction with host Schwann cells and macrophages (Cell, 2017; International Textbook of Leprosy). As a therapeutic target, the membrane is disrupted by drugs like clofazimine, which interferes with the respiratory chain and induces the production of lethal reactive oxygen species (Frontiers in Pharmacology, 2022). Newer agents like bedaquiline specifically target the membrane-embedded c-subunit of ATP synthase to deplete cellular energy reserves, demonstrating high efficacy against both active and dormant bacilli (NEJM, 2024; Antimicrobial Agents and Chemotherapy, 2016). Understanding the integrity and function of the M. leprae membrane is fundamental to developing shorter, more effective treatment regimens for leprosy.

Other names
M. leprae plasma membraneLeprosy bacillus membraneMycobacterial cytoplasmic membraneM. leprae inner membrane
02

Mechanism of action

Inhibition of membrane-bound F-ATP synthase; disruption of the respiratory chain and oxidative phosphorylation; generation of reactive oxygen species (ROS); interference with membrane-associated ion transport and physiological processes.

03

Biological functions

Energy metabolismSolute transportSignal transductionCell wall biosynthesisPermeability barrier
04

Disease associations

InfectionLeprosy
05

Safety considerations

Reversible skin and tissue discoloration (reddish-brown pigmentation)QT interval prolongationDevelopment of drug resistance (e.g., mutations in atpE)Gastrointestinal distressExtremely long half-life leading to prolonged tissue accumulation
06

Interacting drugs

Clofazimine

3 more in the full profile.

07

Biomarkers

Phenolic glycolipid-1 (PGL-1)Bacterial Index (BI)Morphological Index (MI)Acid-fast bacilli (AFB) count

Beyond the preview

Go deeper on Mycobacterium leprae cell membrane (M. leprae cell membrane).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium leprae cell membrane (M. leprae cell membrane).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call